Analytical performance and clinical application of a new rapid bedside assay for the detection of serum cardiac troponin I.

Detection of cardiac troponin I (cTnI) in patients suspected of having an acute coronary syndrome is highly predictive for an adverse outcome. We evaluated a bedside test for cTnI that uses a polyclonal capture antibody and two monoclonal indicator antibodies. Clinical studies were performed in patients with acute coronary syndrome and patients with chest pain but no evidence of acute myocardial injury. The whole-blood, 15-minute assay had a concordance of 98.9% with an ELISA for cTnI and a detection limit of 0.14 microg/L, and the device tolerated temperatures between 4 degrees C and 37 degrees C. Diagnostic sensitivity for myocardial infarction at arrival (3.5 +/- 2.7 h after onset of symptoms) was 60% [creatine kinase isoenzyme MB (CK-MB) mass, 48%; CK activity, 36%; P < 0.01], and 4 h later, diagnostic sensitivity was 98% (CK-MB mass, 91%; CK activity, 61%; P < 0.01). In 38% of the patients with unstable angina, at least one positive cTnI test was found (CK-MB mass, 4%; CK activity, 2%). No false-positive test results were found in renal failure or injury of skeletal muscle. We conclude that the diagnostic efficacy of the cTnI rapid test was comparable with the cTnI ELISA and superior to CK-MB determination. Therefore, this device could facilitate decision-making in patients with chest pain at the point of care.

[1]  J. Chapelle,et al.  Automated quantification of creatine kinase MB isoenzyme in serum by radial partition immunoassay, with use of the Stratus analyzer. , 1990, Clinical chemistry.

[2]  E. Braunwald,et al.  Unstable angina. A classification. , 1989, Circulation.

[3]  C. Heeschen,et al.  Emergency room triage of patients with acute chest pain by means of rapid testing for cardiac troponin T or troponin I. , 1997, The New England journal of medicine.

[4]  A. Henderson,et al.  Discordance between results for serum troponin T and troponin I in renal disease. , 1995, Clinical chemistry.

[5]  P. Cummins,et al.  Regulatory proteins of the myocardium. Atrial and ventricular tropomyosin and troponin-I in the developing and adult bovine and human heart. , 1984, Journal of molecular and cellular cardiology.

[6]  L. Wilkins.  Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction. Results of the TIMI IIIB Trial. Thrombolysis in Myocardial Ischemia. , 1994, Circulation.

[7]  J. Mcmanus.  Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction: Results of the TIMI IIIB trial: The TIMI IIIB Investigators Circulation 89:1545–1556 Apr 1994 , 1994 .

[8]  K. Pulkki,et al.  Troponin I is released in bloodstream of patients with acute myocardial infarction not in free form but as complex. , 1997, Clinical chemistry.

[9]  V. Gökhan Cin,et al.  The prognostic value of serum troponin T in unstable angina. , 1996, International journal of cardiology.

[10]  B. Pau,et al.  Cardiac-specific immunoenzymometric assay of troponin I in the early phase of acute myocardial infarction. , 1993, Clinical chemistry.

[11]  C. MacGeoch,et al.  The human cardiac troponin I locus: assignment to chromosome 19p13.2–19q13.2 , 1991, Human Genetics.

[12]  W. Gibler,et al.  Acute myocardial infarction in chest pain patients with nondiagnostic ECGs: serial CK-MB sampling in the emergency department. The Emergency Medicine Cardiac Research Group. , 1992, Annals of emergency medicine.

[13]  L. Kedes,et al.  cDNA sequence, tissue-specific expression, and chromosomal mapping of the human slow-twitch skeletal muscle isoform of troponin I. , 1990, Genomics.

[14]  T O Stair,et al.  Litigation against the emergency physician: common features in cases of missed myocardial infarction. , 1989, Annals of emergency medicine.

[15]  Use of the initial electrocardiogram to predict in-hospital complications of acute myocardial infarction. , 1986, The New England journal of medicine.

[16]  Eorge,et al.  CARDIAC-SPECIFIC TROPONIN I LEVELS TO PREDICT THE RISK OF MORTALITY IN PATIENTS WITH ACUTE CORONARY SYNDROMES , 2000 .

[17]  Johan Herlitz,et al.  Indications for fibrinolytic therapy in suspected acute myocardial infarction : collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients , 1994 .

[18]  J. Wilkinson,et al.  Comparison of amino acid sequence of troponin I from different striated muscles , 1978, Nature.

[19]  PerVenge,et al.  Relation Between Troponin T and the Risk of Subsequent Cardiac Events in Unstable Coronary Artery Disease , 1996 .

[20]  M. Koelemay,et al.  Failure of new biochemical markers to exclude acute myocardial infarction at admission , 1993, The Lancet.

[21]  C. Fry,et al.  Science of urinary incontinence Report of a Meeting of Physicians and Scientists, University College London , 1994, The Lancet.

[22]  K. Thygesen,et al.  Independent prognostic value of serum creatine kinase isoenzyme MB mass, cardiac troponin T and myosin light chain levels in suspected acute myocardial infarction. Analysis of 28 months of follow-up in 196 patients. , 1995, Journal of the American College of Cardiology.

[23]  Fibrinolytic Therapy Trialists' Collaborative Group.  Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients , 1994, The Lancet.

[24]  S. Perry,et al.  Troponin I from human skeletal and cardiac muscles. , 1978, The Biochemical journal.

[25]  E F Cook,et al.  Sensitivity of routine clinical criteria for diagnosing myocardial infarction within 24 hours of hospitalization. , 1987, Annals of internal medicine.

[26]  C. Herzog,et al.  Cardiac troponin I, cardiac troponin T, and creatine kinase MB in dialysis patients without ischemic heart disease: evidence of cardiac troponin T expression in skeletal muscle. , 1997, Clinical chemistry.

[27]  H. Katus,et al.  Are cardiac troponins reliable serodiagnositic markers of cardiac ischaemia in end-stage renal disease? , 1996, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[28]  Fibrinolytictherapytrialistsf.  Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients , 1994 .

[29]  B. Kay,et al.  Molecular basis of human cardiac troponin T isoforms expressed in the developing, adult, and failing heart. , 1995, Circulation research.

[30]  Jack H. Ladenson,et al.  Cardiac Troponin I A Marker With High Specificity for Cardiac Injury , 1993, Circulation.

[31]  J. Keffer.  The cardiac profile and proposed practice guideline for acute ischemic heart disease. , 1997, American journal of clinical pathology.

[32]  R Roberts,et al.  Electrocardiographic and clinical criteria for recognition of acute myocardial infarction based on analysis of 3,697 patients. , 1983, The American journal of cardiology.

[33]  R B D'Agostino,et al.  Missed diagnoses of acute myocardial infarction in the emergency department: results from a multicenter study. , 1993, Annals of emergency medicine.

[34]  F. Apple,et al.  Prognostic value of serum cardiac troponin I and T in chronic dialysis patients: a 1-year outcomes analysis. , 1997, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[35]  C. Heeschen,et al.  Analytical performance and clinical utility of a sensitive immunoassay for determination of human cardiac troponin I. , 1997, Clinical biochemistry.